Under the terms of the agreement, Paladin has received a cash payment from IMBiotechnologies. In addition, Paladin would also receive a one time milestone payment on first sale of product and a royalty with a capped payment from IMBiotechnologies.
Deal Type Partnership Sub-Category Acquisition Deal Status Announced: 2009-08-13
Deal Participants
Partner 1 (Company) Paladin Labs, Inc. Partner 2 (Company) IMBiotechnologies, Ltd.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index